Mirosława Püsküllüoğlu
-
- Cancer Immunotherapy and Biomarkers 11
- Cancer Treatment and Pharmacology 10
- HER2/EGFR in Cancer Research 9
-
- Advanced Breast Cancer Therapies 6
- Renal cell carcinoma treatment 5
- Gastric Cancer Management and Outcomes 4
-
- Breast Cancer Treatment Studies 6
-
- Monoclonal and Polyclonal Antibodies Research 4
- Co-authors
- Krzysztof KrzemienieckiKrzysztof A. TomaszewskiKamil FijorekRenata Pacholczak‐MadejSebastian PolakSebastián OchenduszkoAgnieszka AdamczykDorota Tomaszewska-Zaremba
- Journals
- Journal of Clinical Oncology (3 papers)SHILAP Revista de lepidopterología (4 papers)Clinical Cancer Research (1 paper)
In The Last Decade
Mirosława Püsküllüoğlu
56 papers receiving 391 citations
Peers
Comparison fields: 5 of 103
- Oncology 176
- Epidemiology 88
- Pulmonary and Respiratory Medicine 79
- Cardiology and Cardiovascular Medicine 54
- Complementary and alternative medicine 19
Countries citing papers authored by Mirosława Püsküllüoğlu
This map shows the geographic impact of Mirosława Püsküllüoğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirosława Püsküllüoğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirosława Püsküllüoğlu more than expected).
Fields of papers citing papers by Mirosława Püsküllüoğlu
This network shows the impact of papers produced by Mirosława Püsküllüoğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirosława Püsküllüoğlu. The network helps show where Mirosława Püsküllüoğlu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mirosława Püsküllüoğlu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 3 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 0 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 0 | |
| 10 | 2023 | 12 | |
| 11 | 2022 | 5 | |
| 12 | 2022 | 6 | |
| 13 | 2016 | 13 | |
| 14 | 2016 | 0 | |
| 15 | 2015 | 23 | |
| 16 | Metronomic therapy — a real progress or a dead end? | 2014 | 1 |
| 17 | 2013 | 23 | |
| 18 | 2013 | 27 | |
| 19 | The role of hyperthermia in oncological treatment | 2012 | 2 |
| 20 | [PARP inhibitors and their role in the therapy of triple-negative metastatic breast cancer]. | 2012 | 5 |
About Mirosława Püsküllüoğlu
Mirosława Püsküllüoğlu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 72 papers that have together received 404 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (11 papers), Cancer Treatment and Pharmacology (10 papers), HER2/EGFR in Cancer Research (9 papers), Advanced Breast Cancer Therapies (6 papers), Breast Cancer Treatment Studies (6 papers), Renal cell carcinoma treatment (5 papers), Gastric Cancer Management and Outcomes (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). The work is most often cited by research in Oncology (176 citations), Epidemiology (88 citations) and Pulmonary and Respiratory Medicine (79 citations). Mirosława Püsküllüoğlu has collaborated with scholars based in Poland, Hungary and Romania. Frequent co-authors include Krzysztof Krzemieniecki, Krzysztof A. Tomaszewski, Kamil Fijorek, Renata Pacholczak‐Madej, Sebastian Polak, Sebastián Ochenduszko, Agnieszka Adamczyk, Dorota Tomaszewska-Zaremba, Izabela Michalak and Aneta L. Zygulska. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.